The Quest For Caffeine You Can Have At Night
Read the original on Astral Codex Ten →
Summary
Practical pharmacology review of how to get caffeine that clears by bedtime, organized around three levers in caffeine metabolism. The enzyme: rutaecarpine induces CYP1A2 about 3x, halving clearance, but the induction lasts days and there is a credible liver-enzyme signal from mouse data and Amazon reports; his own 3-day trial was uninformative. The metabolite: paraxanthine, the main active metabolite with a ~3h half-life and the best safety case, but with mixed user response, possibly from fast metabolizers or receptor-subtype differences. The starting chemical: methylliberine, with a ~1.5h half-life, poorly studied, a CYP1A2 inhibitor, ~50-50 reviews and a possibly stimulant metabolite. Verdict ('just kidding, it's paraxanthine') with doses: methylliberine as a niche option, rutaecarpine only as a rare emergency escape. He updates Ian Musgrave's 2012 critique, and a footnote shows how 'effective half-life' depends on modeling assumptions (receptor occupancy, adenosine balance).
Why this score
Quality 67 · Strong. Strong. A model of Scott's clinician-blogger genre: clear mechanism, honest weighing of thin evidence, and a usable, safety-conscious recommendation on a question many readers actually have. Below his best because the evidence base is anecdotal and the topic is narrow. Med confidence given reliance on reviews and rodent data.
Claude’s paradigm shift 42 · Moderate. Moderate. Synthesizes scattered LessWrong, Reddit and pharmacology sources into a new comparative framework; no new pharmacology.
Real-world impact 1 · Negligible. 1: likely changed some readers' supplement choices; small-scale.